251 Treatment interruption did not impact efficacy or...

The Journal of Investigative Dermatology 2017 / 05 Vol. 137; Iss. 5

251 Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial

Beck, L.A., Mette, D., Zhang, Q., Akinlade, B., Staudinger, H., Graham, N., Pirozzi, G., Ardeleanu, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.02.267
Date:
May, 2017
File:
PDF, 235 KB
english, 2017
Conversion to is in progress
Conversion to is failed